BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 4, 2012
View Archived Issues
Pluristem seeks orphan drug designation for PLX cells
Read More
U.K. clearance for GenSpera's phase II prostate cancer study
Read More
Lorus Therapeutics receives funding to support development of IL-17E
Read More
Wista Laboratories presents new tau aggregation inhibitors
Read More
New antimalarial agents presented by CSIR
Read More
Novartis prepares novel c-Met inhibitors
Read More
Novel cathepsin D inhibitors patented by Merck KGaA
Read More
Novel rabies virus vectors presented by U.S. Department of HHS
Read More
Adenosine-based therapy shows promise for the treatment of priapism
Read More
Bristol-Myers Squibb patents new agents for HIV
Read More
Novel calcium channel blocker induces analgesia in cancer pain model
Read More
Silodosin evaluated for premature ejaculation
Read More
to-BBB receives funding to develop treatments for inherited photoreceptor degeneration
Read More
BMS discovers novel P2Y1 receptor antagonists with antithrombotic activity
Read More
Aerpio Therapeutics completes financing round to support AKB-9778 development
Read More
FDA approves higher dose of Exelon Patch for Alzheimer's disease
Read More
Valeant Pharmaceuticals to acquire Medicis Pharmaceutical
Read More
New series of GPR119 agonists optimized by Bristol-Myers Squibb
Read More
Innate Pharma cleared to begin phase II study of IPH-2102 in AML
Read More
Genentech describes mTOR inhibitor chosen as development candidate
Read More
BioFocus and Ono Pharmaceutical to collaborate on CNS drugs
Read More
Agios and UPenn establish new collaboration
Read More
Genfit cleared to begin phase IIb NASH study in U.S.
Read More
European approval for Pfizer's Inlyta
Read More